MiraiLabo Bioscience, Inc. (Head Office: Chuo-ku, Tokyo; Representative Director: Megumi Tanaka) has achieved measurement of nicotinamide adenine dinucleotide (NAD) levels in human peripheral blood mononuclear cells at the Mirai Kai Medical Corporation/Tokyo Ginza Wellness & Aging Clinic, which provides medical support. NAD) in human peripheral blood mononuclear cells at the Tokyo Ginza Wellness & Aging Clinic.
This is the first time in the world for a private medical institution to measure NAD, a marker of aging, before and after taking nicotinamide mononucleotide (hereinafter referred to as NMN). How much NMN should I take to maintain the NAD level? This will be useful for daily health management.
Click here to read the press release.